What Researchers Did
Scientists tested whether exposing certain cells, including human stem cells, to hyperbaric oxygen changed how well those cells could support and protect nerve cells linked to cochlear implants.
What They Found
This laboratory cell study found that hyperbaric oxygen treatment significantly increased proliferation in both genetically modified NIH3T3/BDNF fibroblasts and native NIH3T3 fibroblasts after five days, compared to normoxic controls. In contrast, the number of mesenchymal stem cells (MSCs) decreased after treatment with 2.0 bar of hyperbaric oxygen. Fluid taken from cultures of these fibroblasts and MSCs significantly increased the survival rate of spiral ganglion neurons, but hyperbaric oxygen treatment did not increase or reduce this neuroprotective effect, meaning the benefit came from the cells' own secretions rather than from the oxygen exposure itself.
Canadian Relevance
No direct Canadian connection identified.
Study Limitations
This was an in vitro cell culture study using cell lines and isolated neurons, not living animals or human patients, so the results may not reflect what would happen in a clinical setting.